5,7-Dihydroxy-2-aminotetralin derivatives: synthesis and assessment of dopaminergic and adrenergic actions
- 1 February 1981
- journal article
- research article
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 24 (2) , 149-153
- https://doi.org/10.1021/jm00134a005
Abstract
Replacement of the catechol 3,4-dihydroxylation pattern of certain adrenergic .beta.-phenethylamines by a resorcinol 3,5-dihydroxylation pattern has led to a greater selectivity of adrenergic agonist effects in certain molecules. This strategy was applied to a series of dopaminergic agents derived from 2-aminotetralin, leading to a 5,7-dihydroxylation pattern. Traditional literature approaches to formation of a tetralin ring with this oxygenation pattern failed. A method was used which involved cyclization of 3,5-dimethoxybenzylsuccinic acid derivatives with pyridinium poly(HF) and subsequent modification of the tetralin ring. The resorcinol-derived 2-aminotetralins were less potent and less active dopaminergic agents than their catechol-derived isomers (5,6-dihydroxy and/or 6,7-dihydroxy). Certain of the subject compounds demonstrated .alpha.- and .beta.1-adrenoceptor activating properties in dogs.This publication has 7 references indexed in Scilit:
- Conformational analogs of dopamine. Synthesis and pharmacological activity of (E)- and (Z)-2-(3,4-dihydroxyphenyl)cyclopropylamine hydrochloridesJournal of Medicinal Chemistry, 1979
- N-Alkyl derivatives of (.+-.)-.alpha.-methyldopamineJournal of Medicinal Chemistry, 1979
- Tetracyclines. 10. Chemical-structural properties of tetracycline derivatives. 5. A total synthesis and structural aspects of racemic 8-oxygenated tetracyclinesJournal of the American Chemical Society, 1979
- Multiple receptors for dopamineNature, 1979
- EFFECT OF DIHYDROXY-2-AMINOTETRALINS (DATS) ON DOPAMINE AND BETA TYPE ADENYLATE CYCLASES1978
- PHARMACOLOGY OF 6,7-DIHYDROXY-2-DIMETHYLAMINOTETRALIN (TL-99) .1. CARDIOVASCULAR ACTIVITY IN DOG AND CAT1978
- INHIBITION OF SYMPATHETIC NERVOUS-SYSTEM BY 5,6-DIHYDROXY-2-DIMETHYLAMINO TETRALIN (M-7), APOMORPHINE AND DOPAMINE1975